Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$135.90
-0.8%
$148.88
$66.03
$161.00
$7.91B0.5366,687 shs225,966 shs
NovoCure Limited stock logo
NVCR
NovoCure
$12.64
+3.3%
$14.49
$10.87
$83.60
$1.36B0.421.34 million shs761,583 shs
Envista Holdings Co. stock logo
NVST
Envista
$20.39
+1.8%
$21.00
$18.95
$38.68
$3.50B1.352.30 million shs1.82 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$30.57
+0.7%
$32.59
$26.27
$43.24
$6.34B0.983.32 million shs1.16 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-4.37%-2.81%-8.69%+3.38%+79.13%
NovoCure Limited stock logo
NVCR
NovoCure
-0.89%+1.49%-6.43%-13.93%-80.91%
Envista Holdings Co. stock logo
NVST
Envista
-1.28%+1.37%-3.54%-17.82%-47.30%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-1.84%-0.30%-6.62%-13.09%-25.85%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.1371 of 5 stars
4.40.00.00.01.81.70.6
NovoCure Limited stock logo
NVCR
NovoCure
4.1363 of 5 stars
4.31.00.04.52.32.50.0
Envista Holdings Co. stock logo
NVST
Envista
4.6574 of 5 stars
4.04.00.03.83.20.01.9
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
4.7123 of 5 stars
3.32.03.33.82.71.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.88
Moderate Buy$173.2527.48% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.56
Moderate Buy$31.13146.34% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.00
Hold$27.9036.83% Upside
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.67
Moderate Buy$39.5029.21% Upside

Current Analyst Ratings

Latest NVST, XRAY, ASND, and NVCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Envista Holdings Co. stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$33.00 ➝ $21.00
4/22/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$116.00 ➝ $116.00
4/18/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
4/18/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$41.00
4/10/2024
NovoCure Limited stock logo
NVCR
NovoCure
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $28.00
4/3/2024
NovoCure Limited stock logo
NVCR
NovoCure
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$49.00 ➝ $42.00
4/2/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $167.00
4/1/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
3/27/2024
NovoCure Limited stock logo
NVCR
NovoCure
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral$21.00
3/27/2024
NovoCure Limited stock logo
NVCR
NovoCure
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$22.00 ➝ $24.00
3/19/2024
NovoCure Limited stock logo
NVCR
NovoCure
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$15.00 ➝ $17.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$288.08M27.46N/AN/A($2.73) per share-49.78
NovoCure Limited stock logo
NVCR
NovoCure
$509.34M2.67N/AN/A$3.39 per share3.73
Envista Holdings Co. stock logo
NVST
Envista
$2.57B1.37$2.56 per share7.97$24.35 per share0.84
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.97B1.60$4.78 per share6.40$15.55 per share1.97

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$521.07M-$9.25N/AN/AN/A-180.61%-16,574.15%-55.10%5/2/2024 (Confirmed)
NovoCure Limited stock logo
NVCR
NovoCure
-$207.04M-$1.95N/AN/AN/A-40.65%-51.63%-17.90%5/2/2024 (Confirmed)
Envista Holdings Co. stock logo
NVST
Envista
-$100.20M-$0.61N/A12.593.79-3.90%6.31%4.07%5/1/2024 (Confirmed)
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$132M-$0.62N/A12.791.25-3.33%11.14%5.22%5/2/2024 (Confirmed)

Latest NVST, XRAY, ASND, and NVCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$1.57-$1.60-$0.03N/AN/AN/A
5/2/2024N/A
NovoCure Limited stock logo
NVCR
NovoCure
-$0.42N/A+$0.42N/AN/AN/A  
5/2/2024N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.42N/A-$0.42N/AN/AN/A  
5/1/2024N/A
Envista Holdings Co. stock logo
NVST
Envista
$0.31N/A-$0.31N/AN/AN/A  
2/29/2024Q4 23
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.43$0.44+$0.01$0.56$972.61 million$1.01 billion    
2/22/2024Q4 2023
NovoCure Limited stock logo
NVCR
NovoCure
-$0.53-$0.45+$0.08-$0.45$133.80 million$133.80 million      
2/7/2024Q4 2023
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$2.15-$1.66+$0.49-$1.66$97.02 million$148.62 million
2/7/2024Q4 2023
Envista Holdings Co. stock logo
NVST
Envista
$0.33$0.29-$0.04$1.85$638.37 million$645.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.642.09%+11.87%N/A 13 Years

Latest NVST, XRAY, ASND, and NVCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
quarterly$0.161.92%3/27/20243/29/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
3.56
2.50
NovoCure Limited stock logo
NVCR
NovoCure
1.57
5.78
5.56
Envista Holdings Co. stock logo
NVST
Envista
0.33
2.23
1.90
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.55
1.38
0.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Envista Holdings Co. stock logo
NVST
Envista
N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
40.00%
NovoCure Limited stock logo
NVCR
NovoCure
5.67%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.74%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
87958.22 million34.93 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,453107.61 million101.51 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,800171.86 million169.62 millionOptionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
15,000207.36 million205.83 millionOptionable

NVST, XRAY, ASND, and NVCR Headlines

SourceHeadline
Jennison Associates LLC Purchases New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Jennison Associates LLC Purchases New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 26 at 6:57 AM
Sumitomo Mitsui Trust Holdings Inc. Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Sumitomo Mitsui Trust Holdings Inc. Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 25 at 4:54 AM
DENTSPLY SIRONA (XRAY) Set to Announce Earnings on ThursdayDENTSPLY SIRONA (XRAY) Set to Announce Earnings on Thursday
americanbankingnews.com - April 25 at 2:14 AM
Dentsply Sirona: Im Buying The Pullback In This Medtech LeaderDentsply Sirona: I'm Buying The Pullback In This Medtech Leader
seekingalpha.com - April 24 at 5:29 PM
Dentsply Sirona: Im Buying The Pullback In This Medtech LeaderDentsply Sirona: I'm Buying The Pullback In This Medtech Leader
seekingalpha.com - April 24 at 5:29 PM
Why Dentsply International (XRAY) is a Top Value Stock for the Long-TermWhy Dentsply International (XRAY) is a Top Value Stock for the Long-Term
zacks.com - April 22 at 10:46 AM
Cooke & Bieler LP Has $251.33 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Cooke & Bieler LP Has $251.33 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 21 at 7:35 AM
Allspring Global Investments Holdings LLC Lowers Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Allspring Global Investments Holdings LLC Lowers Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 20 at 5:13 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Barrington ResearchDENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Barrington Research
americanbankingnews.com - April 20 at 3:18 AM
DENTSPLY Sirona IncDENTSPLY Sirona Inc
money.usnews.com - April 19 at 8:16 PM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 47% Below Their Intrinsic Value EstimateDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 47% Below Their Intrinsic Value Estimate
finance.yahoo.com - April 19 at 3:16 PM
Ninety One UK Ltd Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Ninety One UK Ltd Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 19 at 8:54 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Given Outperform Rating at Barrington ResearchDENTSPLY SIRONA (NASDAQ:XRAY) Given Outperform Rating at Barrington Research
marketbeat.com - April 18 at 10:28 AM
Asset Management One Co. Ltd. Has $73,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Asset Management One Co. Ltd. Has $73,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 15 at 4:43 AM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLCDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLC
marketbeat.com - April 12 at 9:38 PM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Moderate Buy" from BrokeragesDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - April 10 at 2:29 AM
Dentsply Sirona to Host First Quarter Conference Call on May 2ndDentsply Sirona to Host First Quarter Conference Call on May 2nd
globenewswire.com - April 9 at 4:30 PM
Cambiar Investors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Cambiar Investors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - April 7 at 8:24 PM
Heres Why Dentsply International (XRAY) is a Strong Value StockHere's Why Dentsply International (XRAY) is a Strong Value Stock
zacks.com - April 4 at 10:45 AM
Former Dentsply Sirona CEO joins healthcare-focused PE firmFormer Dentsply Sirona CEO joins healthcare-focused PE firm
beckersdental.com - April 2 at 8:58 PM
Cone Beam Imaging Systems Market Future Growth with Technology and Current Trends 2024 to 2032Cone Beam Imaging Systems Market Future Growth with Technology and Current Trends 2024 to 2032
taiwannews.com.tw - April 2 at 3:20 PM
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio NowReasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
zacks.com - April 2 at 10:46 AM
3M Spinoff Solventum Stock Is Down. 3M Stock Is Not. What Happens Next.3M Spinoff Solventum Stock Is Down. 3M Stock Is Not. What Happens Next.
msn.com - April 1 at 3:38 PM
Raymond James & Associates Acquires 234,322 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)Raymond James & Associates Acquires 234,322 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
marketbeat.com - March 30 at 4:33 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ascendis Pharma A/S logo

Ascendis Pharma A/S

NASDAQ:ASND
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
NovoCure logo

NovoCure

NASDAQ:NVCR
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Envista logo

Envista

NYSE:NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
DENTSPLY SIRONA logo

DENTSPLY SIRONA

NASDAQ:XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina